BRD4 and prostate carcinoma: Our study provides novel insight into the epigenetic regulation of metastatic dissemination in prostate cancer (PCa), identifying the BET family protein BRD4 as a key driver of the H19/cell adhesion molecule axis that promotes collective cell migration.